BAC
Bank of America Corporation
BAC has the edge over SF overall, supported by stronger modeled upside and lower modeled downside.
SF
Stifel Financial Corp.
SF's outlook is improving, though it still trails on the overall score.
BAC Fundamentals
| Metric | Status |
|---|---|
| Healthy | |
| Strong | |
| N/A | |
| N/A |
BAC's revenue and profitability are currently healthy. Free cash flow and net leverage aren't meaningful measures for financial services companies like BAC.
SF Fundamentals
| Metric | Status |
|---|---|
| Stable | |
| Strong | |
| N/A | |
| N/A |
SF's profitability is currently strong, and its revenue is stable. Free cash flow and net leverage aren't meaningful measures for financial services companies like SF.
BAC PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Cheap | 9.4x | $39.50 | -22% |
| Forward | 10x | $50.51 | — |
| Current | 12x | $50.51 | — |
| Fair | 13x | $53.81 | +6.5% |
| Expensive | 15x | $62.23 | +23% |
Historical ranges are pointers, not guarantees.
BAC has the edge over SF in the historical PE scenario, which offers more potential upside but is not a forecast.
SF PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Cheap | 9.8x | $56.62 | -22% |
| Forward | 10x | $72.26 | — |
| Fair | 13x | $76.62 | +6% |
| Current | 13x | $72.26 | — |
| Expensive | 19x | $109 | +50% |
Historical ranges are pointers, not guarantees.
SF's PE is 13x, but its earnings don't support one, so it isn't a reliable read right now.
BAC Forward outlook
| Metric | Outlook |
|---|---|
| Improving | |
| Growth | |
| Growth | |
| Strongly improving | |
| Limited | |
| Moderate |
Analysts expect earnings and revenue growth for BAC, with profitability improving.
SF Forward outlook
| Metric | Outlook |
|---|---|
| Improving | |
| Growth | |
| Growth | |
| Improving | |
| Limited | |
| High |
Analysts expect earnings and revenue growth for SF, with profitability improving.
BAC Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $4.92 | +17% |
| Q3 2026 | $4.19 | +14% |
| Q2 2026 | $4.34 | +27% |
| Q1 2026 | $4.02 | +20% |
| Q4 2025 | $3.81 | +19% |
| Q3 2025 | $3.66 | +33% |
| Q2 2025 | $3.41 | +20% |
| Q1 2025 | $3.35 | +16% |
| Q4 2024 | $3.21 | +4.2% |
BAC's earnings per share have climbed steadily: $4.19 over the past year, up 14% from the year before, and higher year over year for eight quarters in a row.
SF Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $6.95 | +21% |
| Q3 2026 | $5.75 | +52% |
| Q2 2026 | $5.58 | +62% |
| Q1 2026 | $5.13 | +47% |
| Q4 2025 | $3.91 | -6.2% |
| Q3 2025 | $3.78 | +2.4% |
| Q2 2025 | $3.45 | +9.9% |
| Q1 2025 | $3.49 | +19% |
| Q4 2024 | $4.17 | +46% |
SF earned $5.75 per share over the past year, up 52% from the year before. Its recent earnings include one-off gains.
BAC Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $30B | +6.7% |
| Q2 2026 | $31.6B | +19% |
| Q1 2026 | $30.3B | +11% |
| Q4 2025 | $31.2B | +23% |
| Q3 2025 | $28.1B | +11% |
| Q2 2025 | $26.5B | +4.3% |
| Q1 2025 | $27.4B | +6% |
| Q4 2024 | $25.3B | +15% |
BAC's revenue has grown year over year for 10 quarters in a row: $30B last quarter, up 6.7% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 30% | -3.7 points |
| Q2 2026 | 37% | +7.6 points |
| Q1 2026 | 34% | +4.7 points |
| Q4 2025 | 40% | +12 points |
| Q3 2025 | 34% | +4.8 points |
| Q2 2025 | 29% | -0.7 points |
| Q1 2025 | 30% | +1.5 points |
| Q4 2024 | 28% | +14 points |
BAC has the edge over SF on profitability, with a higher operating margin.
SF Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $1.4B | -0.2% |
| Q2 2026 | $1.5B | +13% |
| Q1 2026 | $1.5B | +18% |
| Q4 2025 | $1.6B | +14% |
| Q3 2025 | $1.4B | +17% |
| Q2 2025 | $1.3B | +5.4% |
| Q1 2025 | $1.3B | +7.9% |
| Q4 2024 | $1.4B | +19% |
SF's revenue is growing: $1.4B last quarter, about level with the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 22% | +1.7 points |
| Q2 2026 | 21% | +4 points |
| Q1 2026 | 22% | +17 points |
| Q4 2025 | 20% | +0.2 points |
| Q3 2025 | 20% | +2.3 points |
| Q2 2025 | 17% | -2 points |
| Q1 2025 | 5% | -14 points |
| Q4 2024 | 20% | +1.5 points |
SF's operating margin was 22% last quarter, up 1.7 points from the same quarter a year ago.
BAC Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | -$6.5B | -114% |
| Q2 2026 | $29B | +$38.2B |
| Q1 2026 | $41.8B | +$44B |
| Q4 2025 | -$22.9B | -189% |
| Q3 2025 | $46.9B | +$84.2B |
| Q2 2025 | -$9.1B | -150% |
| Q1 2025 | -$2.2B | +$13.4B |
| Q4 2024 | $25.9B | -21% |
BAC's free cash flow was $41.4B over the past year, down 33% from the year before. Free cash flow isn't a meaningful measure for financial services companies like BAC.
SF Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $752.9M | +134% |
| Q2 2026 | $61.3M | -90% |
| Q1 2026 | -$390.4M | -$162.6M |
| Q4 2025 | $369M | -46% |
| Q3 2025 | $321.1M | +73% |
| Q2 2025 | $592.7M | +242% |
| Q1 2025 | -$227.8M | +$391.6M |
| Q4 2024 | $677.2M | +158% |
SF has the edge over BAC on cash flow, with more consistent year-over-year improvement.
BAC Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | -1% | -72M shares |
| 1 year | -5.3% | -405M shares |
| 3 years | -11% | -854M shares |
| 5 years | -15% | -1.3B shares |
| Available history | -24% | -2.2B shares |
BAC has the edge over SF on shareholder dilution, with a more favorable share count trend.
| Quarter | Spent |
|---|---|
| Q3 2026 | $6B |
| Q2 2026 | $6B |
| Q1 2026 | $7.2B |
| Q4 2025 | $6.3B |
| Q3 2025 | $5.3B |
| Q2 2025 | $5.3B |
| Q1 2025 | $4.5B |
| Q4 2024 | $3.5B |
BAC spent $25.6B buying back its own shares over the past year, up 37% from the year before.
SF Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | -0.9% | -1.5M shares |
| 1 year | -3% | -4.9M shares |
| 3 years | -5.7% | -9.6M shares |
| 5 years | -9.9% | -17.6M shares |
| Available history | -8.5% | -14.9M shares |
SF has 160M diluted shares, down 3% from a year ago, with $428M in buybacks over the past year.
| Quarter | Spent |
|---|---|
| Q3 2026 | $122M |
| Q2 2026 | $172.1M |
| Q1 2026 | $96.4M |
| Q4 2025 | $37.5M |
| Q3 2025 | $31.2M |
| Q2 2025 | $83M |
| Q1 2025 | $93.2M |
| Q4 2024 | $45.6M |
SF spent $428M buying back its own shares over the past year, up 69% from the year before.
BAC Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | 6.4x | High |
| Q2 2026 | 6.7x | High |
| Q1 2026 | 7.1x | High |
| Q4 2025 | 7.7x | High |
| Q3 2025 | 8.3x | High |
| Q2 2025 | 8.8x | High |
| Q1 2025 | 8.6x | High |
| Q4 2024 | 9.0x | High |
BAC's net debt is about 6.4 years of its operating earnings (EBITDA), down from 8.3 years a year ago. Net leverage isn't a meaningful measure for financial services companies like BAC.
SF Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | -0.8x | Net Cash |
| Q2 2026 | -1.2x | Net Cash |
| Q1 2026 | -1.9x | Net Cash |
| Q4 2025 | -1.8x | Net Cash |
| Q3 2025 | -2.9x | Net Cash |
| Q2 2025 | -1.5x | Net Cash |
| Q1 2025 | -2.5x | Net Cash |
| Q4 2024 | -2.1x | Net Cash |
SF has the edge over BAC on leverage, with a lower net debt burden relative to earnings.
BAC Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 37.1 | Neutral |
| Stochastic | 4.9 | Oversold |
BAC's weekly RSI is 37 (neutral) and its Stochastic is 5 (oversold).
SF Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 46.3 | Neutral |
| Stochastic | 22.6 | Neutral |
SF's weekly RSI is 46 (neutral) and its Stochastic is 23 (neutral).
BAC PE vs Financial Services Sector
| Metric | BAC | Sector median | Relative |
|---|---|---|---|
| PE | 12x | 13x | 7.5% below |
| PE % | 40 | 63 | 23 pts below |
BAC has the edge over SF on valuation relative to its sector.
SF PE vs Financial Services Sector
| Metric | SF | Sector median | Relative |
|---|---|---|---|
| PE | 13x | 13x | 3.5% below |
| PE % | 44 | 63 | 19 pts below |
SF is trading at 13x earnings, in line with the Financial Services sector's median of 13x, though its earnings don't support one.
BAC Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $52.1 | 3% below |
| 20 week MA | $57.8 | 13% below |
| 50 week MA | $54.7 | 7.7% below |
| 100 week MA | $50.5 | 0% below |
| 200 week MA | $42.5 | 19% above |
BAC has fallen below most of its moving averages, though it's still 19% above its 200-week average.
SF Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $69.4 | 4.1% above |
| 20 week MA | $75.6 | 4.5% below |
| 50 week MA | $77.1 | 6.3% below |
| 100 week MA | $73.8 | 2.1% below |
| 200 week MA | $61.6 | 17% above |
SF has the edge over BAC on trend strength, trading above more of its moving averages.
BAC Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $35.4 | $30.0 | -15% |
| 2021 | $30.0 | $44.4 | +48% |
| 2022 | $44.4 | $32.5 | -27% |
| 2023 | $32.5 | $33.7 | +3.7% |
| 2024 | $33.7 | $44.3 | +32% |
| 2025 | $44.3 | $56.2 | +27% |
| 2026 YTD | $56.2 | $50.5 | -10% |
BAC has the edge over SF on returns for 2026, with the stronger performance.
SF Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $27.4 | $34.1 | +24% |
| 2021 | $34.1 | $46.1 | +35% |
| 2022 | $46.1 | $38.6 | -16% |
| 2023 | $38.6 | $46.1 | +19% |
| 2024 | $46.1 | $71.1 | +54% |
| 2025 | $71.1 | $85.8 | +21% |
| 2026 YTD | $85.8 | $72.3 | -16% |
SF has finished higher in five of the last six years. It's down 16% so far in 2026.